In8bio Valuation
| INAB Stock | USD 1.99 0.09 4.74% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. In8bio Inc owns a latest Real Value of $4.47 per share. The recent price of the firm is $1.99. Our model calculates the value of In8bio Inc from analyzing the firm fundamentals such as Return On Asset of -0.8, shares outstanding of 9.77 M, and EBITDA of (26.94 M) as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that In8bio's price fluctuation is very risky at this time. Calculation of the real value of In8bio Inc is based on 3 months time horizon. Increasing In8bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since In8bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of In8bio Stock. However, In8bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.99 | Real 4.47 | Hype 1.89 | Naive 1.81 |
The real value of In8bio Stock, also known as its intrinsic value, is the underlying worth of In8bio Inc Company, which is reflected in its stock price. It is based on In8bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of In8bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of In8bio Inc helps investors to forecast how In8bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of In8bio more accurately as focusing exclusively on In8bio's fundamentals will not take into account other important factors: About In8bio Valuation
The stock valuation mechanism determines In8bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of In8bio. We calculate exposure to In8bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of In8bio's related companies.IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York. In8Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
Complementary Tools for In8bio Stock analysis
When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |